Can-Fite BioPharma Ltd. (CANF) Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period

Prices Financial Statements ›Discontinued ›News Ratios Analyst Ratings Insider Transactions SEC Filings Roast Me Breakdown

Balance Sheet ›Income Statement ›Expense Statement ›Shareholders' Equity ›Cash Flow ›Notes ›

Receivables ›Deposit Assets Payables and Accruals ›Lessee, Operating Lease, Liability, to be Paid, Year Four Debt ›Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Equity ›Compensation Related Costs ›Deferred Tax Assets, Gross ›Long-Lived Assets Derivative Instruments and Hedging Activities ›Related Party Transaction, Amounts of Transaction Government Contract Receivable Financial Services ›Investment Owned, Balance, Shares Adjustments For Increase Decrease In Other Operating Payables Adjustments For Increase Decrease In Trade Account Payable Assets Average Foreign Exchange Rate Cash Flows From Used In Operations Cash Flows From Used In Operations Before Changes In Working Capital Current Accrued Expenses And Other Current Liabilities Current Assets Current Government Grants Leases ›Current Liabilities Current Prepaid Expenses Deferred Income Classified As Current Deferred Income Classified As Noncurrent Description Of Expected Volatility Share Options Granted Description Of Risk Free Interest Rate Share Options Granted Equity Equity And Liabilities Equity Attributable To Owners Of Parent Financial Liabilities At Fair Value Through Profit Or Loss Shares ›Increase Decrease Through Transfers And Other Changes Equity Issued Capital Noncontrolling Interests Noncurrent Assets Noncurrent Liabilities Other Current Payables Other Payables Other Reserves Preconfirmation, Short-term Investments Prepayments And Accrued Income Profit Loss Attributable To Noncontrolling Interests Profit Loss Attributable To Owners Of Parent Profit Loss Before Tax Profit Loss From Continuing Operations Proportion Of Ownership Interest In Joint Venture Retained Earnings Rightofuse Assets Share Premium Tax Rate Effect From Change In Tax Rate Trade And Other Current Payables Trade And Other Current Payables To Trade Suppliers Treasury Shares Wages And Salaries

Share-Based Payment Arrangement, Disclosure ›Adjustments For Share-based Payments Increase Decrease Through Share-based Payment Transactions Reserve Of Share-based Payments

Per Share Weighted Average Price of Shares Purchased Number of Shares Available for Grant Shares Issued in Period

Can-Fite BioPharma Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period

Can-Fite BioPharma Ltd. (CANF) reported Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period of 1.24 million shares for the 12-month period ending 2019-12-31, per its 6-K filed 2020-06-01.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod · last filed 2020-06-01

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 12 month
2019-12-31	1.24M shares 6-K · filed 2020-06-01
2017-12-31	970.00K shares 6-K · filed 2020-06-01